» Articles » PMID: 31866868

Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review

Overview
Journal Front Pharmacol
Date 2019 Dec 24
PMID 31866868
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Bioactive compounds from medicinal plants with anti-inflammatory and immunosuppressive effects have been emerging as important sources of drugs for the treatment of inflammatory disorders. Triptolide, a diterpene triepoxide, is a pharmacologically active compound isolated from Hook F (TwHF) that is used as a remedy for inflammatory and autoimmune diseases. As the most promising bioactive compound obtained from TwHF, triptolide has attracted considerable interest recently, especially for its potent anti-inflammatory and immunosuppressive activities. Over the past few years, an increasing number of studies have been published emphasizing the value of triptolide in the treatment of diverse inflammatory disorders. Here, we systematically review the mechanism of action and the therapeutic properties of triptolide in various inflammatory diseases according to different systematic organs, including lupus nephritis, inflammatory bowel disease, asthma, and rheumatoid arthritis with pubmed and Embase. Based on this review, potential research strategies might contribute to the clinical application of triptolide in the future.

Citing Articles

Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy.

Shoari A, Ashja Ardalan A, Dimesa A, Coban M Biomolecules. 2025; 15(1).

PMID: 39858430 PMC: 11762759. DOI: 10.3390/biom15010035.


The Potential of Naturally Derived Compounds for Treating Chronic Kidney Disease: A Review of Autophagy and Cellular Senescence.

Teh Y, Mualif S, Izzati Mohd Noh N, Lim S Int J Mol Sci. 2025; 26(1.

PMID: 39795863 PMC: 11719669. DOI: 10.3390/ijms26010003.


Therapeutic Potential of Terpenoids in Cancer Treatment: Targeting Mitochondrial Pathways.

Guo J, Huang M, Hou S, Yuan J, Chang X, Gao S Cancer Rep (Hoboken). 2024; 7(9):e70006.

PMID: 39234662 PMC: 11375335. DOI: 10.1002/cnr2.70006.


Seaweeds as Source of Bioactive Pigments with Neuroprotective and/or Anti-Neurodegenerative Activities: Astaxanthin and Fucoxanthin.

Guardado Yordi E, Perez Martinez A, Radice M, Scalvenzi L, Abreu-Naranjo R, Uriarte E Mar Drugs. 2024; 22(7).

PMID: 39057436 PMC: 11277739. DOI: 10.3390/md22070327.


Knockout Genes in Bowel Anastomoses: A Systematic Review of Literature Outcomes.

Geropoulos G, Psarras K, Koimtzis G, Fornasiero M, Anestiadou E, Geropoulos V J Pers Med. 2024; 14(6).

PMID: 38929776 PMC: 11205243. DOI: 10.3390/jpm14060553.


References
1.
Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

2.
Li F, Lu X, Liang X, Zhou H, Xue B, Liu X . Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation. J Neuroimmunol. 2004; 148(1-2):24-31. DOI: 10.1016/j.jneuroim.2003.10.054. View

3.
Cope A, Schulze-Koops H, Aringer M . The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol. 2007; 25(5 Suppl 46):S4-11. View

4.
Farber H, Loscalzo J . Pulmonary arterial hypertension. N Engl J Med. 2004; 351(16):1655-65. DOI: 10.1056/NEJMra035488. View

5.
Gu W, Brandwein S . Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol. 1998; 20(8):389-400. DOI: 10.1016/s0192-0561(98)00035-6. View